NCT03255434View on ClinicalTrials.gov

LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

July 28, 2022

Study Completion Date

July 31, 2025

Conditions
Stage III Colon Cancer
Interventions
DRUG

Oxaliplatin

Simplified FOLFOX 4 regimen: Association of Oxaliplatin (85 mg/m² ) + simplified LV5FU2 Length of a cycle : 2 days Interval between 2 cycles : 2 weeks (D1=D15) Expected number of cycles: 12

DRUG

Oxaliplatin LBM

Simplified FOLFOX 4 regimen: Association of Oxaliplatin (LBM) + simplified LV5FU2

Trial Locations (11)

13

CHU La TIMONE, Marseille

13003

Hôpital Européen, Marseille

14076

Centre François Baclesse, Caen

34000

Centre hospitalier régional et universitaire de Montpellier, Montpellier

34298

Institut regional du Cancer - Val d Aurelle, Montpellier

35042

Centre Eugène Marquis, Rennes

54511

CHU de Nancy, Vandœuvre-lès-Nancy

54519

Insitut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

66000

Hôpital Saint-Jean, Perpignan

Unknown

AP-HP Hôpital Saint-Louis, Paris

Centre Paul Strauss, Strasbourg

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER